Skip to content
Home

Hypnotic (sleep-inducing medication)

Hypnotics are drugs that promote sleep or deep sedation. This article explains their types, history, clinical uses, risks like dependence, and notable examples and distinctions.

Overview

A hypnotic is a medication designed primarily to induce or maintain sleep and, in higher doses, to produce deep sedation for procedures. Hypnotics belong to a broader set of psychoactive agents that act on the central nervous system to reduce arousal and promote drowsiness. Clinicians typically reserve hypnotics for short-term management of insomnia or for procedural sedation because of their potential for tolerance, dependence, and adverse effects.

Image gallery

2 Images

Types and characteristics

Modern hypnotics fall into several pharmacological classes. Each class differs in onset, duration, mechanism, and side-effect profile. Common categories include:

  • Benzodiazepines — work on GABA receptors to produce sedation, muscle relaxation and anxiolysis; effective but associated with tolerance and withdrawal after extended use.
  • Z-drugs (nonbenzodiazepine receptor agonists) — developed to target sleep with fewer anxiolytic or muscle-relaxant effects; examples are widely used for short-term insomnia.
  • Barbiturates — older sedative-hypnotics with a narrow safety margin; historically important but largely replaced due to overdose risk.
  • Melatonin receptor agonists and antihistamines — act on sleep-regulating systems and are sometimes used when benzodiazepines or Z-drugs are inappropriate.
  • Orexin antagonists — a newer class that reduces wakefulness by blocking orexin signalling.

History and development

The development of hypnotic agents spans more than a century. Barbiturates emerged in the late 19th and early 20th centuries as some of the first reliable sedatives. In the mid-20th century, benzodiazepines became popular because they were safer than barbiturates for many indications. Later decades saw the introduction of nonbenzodiazepine "Z-drugs" and other targeted agents aimed at improving safety and reducing next-day impairment.

Clinical uses and examples

Hypnotics are prescribed primarily for short-term treatment of insomnia and, when appropriate, for premedication or anesthesia. Non-drug approaches such as cognitive behavioral therapy for insomnia (CBT-I) are recommended as first-line long-term treatment. Clinicians consider patient age, comorbid conditions, and risk factors when choosing an agent.

  • Examples of hypnotic agents include benzodiazepines, Z-drugs, melatonin agonists and orexin receptor antagonists.
  • Some agents used in anesthesia and procedural sedation are classified by their hypnotic properties.

Risks, safety and notable distinctions

Hypnotics can cause side effects such as daytime drowsiness, impaired coordination, memory disturbances, and, with prolonged use, tolerance and dependence. Combining hypnotics with alcohol or other central nervous system depressants increases the risk of respiratory depression. Older adults are particularly vulnerable to falls and cognitive impairment from sedative drugs.

  • Regulatory and clinical guidelines generally advise using hypnotics at the lowest effective dose and for the shortest feasible duration.
  • Rebound insomnia and withdrawal symptoms may follow abrupt discontinuation after sustained use.

Notable examples and misuse

Some hypnotic compounds have been misused because of powerful sedative or amnesic effects. One well-known example of a potent benzodiazepine is Rohypnol, which has been associated with illicit use. Because of misuse potential and adverse effects, many hypnotics are controlled substances in various jurisdictions.

For further reading on sleeping medications and their clinical use, see general prescribing guidance and pharmacology resources: sleep medication overview, psychoactive drug classes, and safety advisories regarding dependence and side effects: risks and dependency information.

Related articles

Author

AlegsaOnline.com Hypnotic (sleep-inducing medication)

URL: https://en.alegsaonline.com/art/46189

Share

Sources